Cardio Oncology Related Topics 
European Journal of Heart Failure
DECEMBER 20, 2023
Abstract Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant diseases.
American College of Cardiology
JUNE 11, 2024
The following are key points to remember from a state-of-the-art review on social determinants of health (SDoH) in cardio-oncology.
Becker's Hospital Review - Cardiology
DECEMBER 14, 2023
NYU Langone Health in New York City has appointed Michelle Bloom, MD, as system director of its cardio-oncology program, effective Dec.
HCPLive
FEBRUARY 13, 2024
and sleep apnea prevalence in cardio-oncology patients was the same or greater than other traditional risk factors. Sleep apnea prevalence in cardiology patients was similar to the rates in patients with heart failure.,
DAIC
JUNE 19, 2024
The review underscores the critical need to consider environmental factors, especially air pollution, in cardio-oncology risk assessment and patient management,” said Xiaoquan Rao , MD, PhD, senior author of the study and a cardiologist at Tongji Hospital at the Tongji Medical College in Wuhan, China.
Medical Xpress - Cardiology
DECEMBER 13, 2024
However, experts in cardio-oncology from the European Society of Cardiology (ESC) emphasize that heart and cardiovascular health must be included as early as possible in the patient's cancer treatment plan to ensure the best possible outcomes.
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
Cangrelor, a potent intravenous P2Y12 platelet inhibitor, has demonstrated effectiveness in reducing ischemic events without a corresponding increase in severe bleeding during percutaneous coronary intervention, as evidenced by the CHAMPION-PHOENIX trial.
Expert insights. Personalized for you.
75 
Let's personalize your content